Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Group ACYW 135 Meningococcal Conjugate Vaccine
- Development stage
- Unknown
- Lead developer
- CanSino Biologics
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Group ACYW 135 Meningococcal Conjugate Vaccine is a **quadrivalent conjugate vaccine** being developed by **Novo Medi Sciences** for prevention of **meningococcal disease**. The product is intended to induce protective humoral immune responses against *Neisseria meningitidis* serogroups **A, C, W-135, and Y** by presenting capsular polysaccharide antigens in conjugated form to enhance immunogenicity and generate bactericidal antibodies. On Novo Medi Sciences' pipeline, this vaccine is listed in **CTA / Phase 1** development for meningococcal disease.
- Other names
- meningococcal conjugate vaccine groups A C W-135 Yquadrivalent meningococcal conjugate vaccinemeningococcal conjugate vaccineGroup ACYW-135 Meningococcal Conjugate Vaccine
Beyond the preview
Go deeper on Group ACYW 135 Meningococcal Conjugate Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Group ACYW 135 Meningococcal Conjugate Vaccine.